ClinicalTrials.Veeva

Menu

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children

S

Sichuan Provincial People's Hospital

Status

Enrolling

Conditions

Perioperative Respiratory Adverse Events

Study type

Observational

Funder types

Other

Identifiers

NCT06354569
2022.232

Details and patient eligibility

About

to explore the risk factors of perioperative respiratory adverse events in children, and to establish a risk prediction model of perioperative respiratory adverse events in children

Full description

600 children undergoing elective surgery under general anesthesia were selected. Age, sex, weight, height, allergy history, past history, snoring, passive smoking, abnormal laboratory examination and chest X-ray before operation, upper respiratory tract infection 14 days before operation, Operation Site, working years of anesthesiologist, anesthesia method, Operation Duration, anesthesia duration, perioperative vital signs and respiratory adverse events were collected. The risk prediction model of perioperative respiratory adverse events in children was established by using LASSO (least absolute shrinkage and selection operator) algorithm and gradient boosting machine (GBM) algorithm to screen the relevant data collected during routine diagnosis and treatment, such as demographic characteristics, physical conditions, airway sensitivity, environmental sensitivity and anesthesia management

Enrollment

600 estimated patients

Sex

All

Ages

1 month to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1)Children aged 1 month to 12 years, (2) ASA Class I or II, (3)scheduled for surgery under general anesthesia

Exclusion criteria

-(1)Children and guardians declined to participate in the study (2) children with severe chronic respiratory, cardiovascular, central nervous system, liver and kidney diseases; (3) on the day of operation, the patients had active URTI and pulmonary infection, such as severe nasal obstruction, large amount of airway secretion, severe cough, fever (body temperature > 37.5 ° C) , in addition to the above symptoms, signs of pulmonary consolidation and/or wet Rales, or peripheral white blood cells > 10 × 109/L or < 4 × 109/L with or without left shift of the nucleus, and chest X-ray showed new patchy, patchy infiltrative shadows or interstitial changes.

(4) the child had severe anaphylaxis to narcotic drugs

Trial contacts and locations

1

Loading...

Central trial contact

Yanyu Liu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems